Male Infertility Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Male Infertility Treatment Market by Product Type ( Drugs (Clomiphene, Tamoxifen, Others), Hormones (Gonadotropin hormone, Recombinant Follicle Stimulation Hormone), Supplements, Others)), distribution channel (Hospital Pharmacies, Retail Pharmacies, Others) and Geography

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Male Infertility Treatment Market is forecasted to value over USD 5.3 billion by 2027 end and register a CAGR of 4.8% from the forecast period 2021-2027. male infertility refers to the inability of male to cause pregnancy in a fertile woman. A variety of the problems ranging from hormonal disturbances to physical, psychological problems can cause male infertility. Hormonal problems include hyperprolactinemia, hypothyroidism, panhypopituitarism and others. Physical problems include varicocele, torsion, damaged sperm ducts and others. Furthermore, Erectile dysfunction, premature ejaculation and ejaculatory incompetence may lead to male infertility. Although many treatments are available for male infertility, in many cases treatment will not work. In many of the cases, male infertility is caused by testicular damage that leads to the inability of sperm production. In addition, low sperm production and poor sperm quality are also major causes of male infertility. Drugs, hormonal therapy, and assisted reproductive technology make up the global male infertility treatment market (ART). Clomiphene citrate and tamoxifen are two drugs used to treat male infertility. Human chorionic gonadotropin hormone (hCG) and recombinant follicle stimulating hormone (rFSH) are two types of hormone therapy (rFSH). Patients are given gonadotropin treatment to increase their testosterone levels. If these medicines do not work after 6 to 12 months of treatment, assisted reproductive technologies may be a possibility. In vitro fertilization-embryo transfer (IVF-ET), gamete intrafallopian transfer (GIFT), frozen embryo transfer (FET), and zygote intrafallopian transfer (ZIFT) are the several types of assisted reproductive technologies (ZIFT).

Male Infertility Treatment Market

MARKET SUMMARY
-
4.8%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 4.8%
  • Largest Market– North America
  • Fastest Growing Market–  Europe

Male Infertility Treatment Market

  • The report on global male infertility treatment market gives historical, current and future market sizes (US$ Bn) based on product type, distribution channel and region.
  • Male Infertility Treatment Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Market Key Players
  • OncBioMune Pharmaceutical
  • The Merck Group
  • Endo International plc
  • Sanofi
  • SalNature
  • Active Bio Life Science GmbH
  • Bayer AG
  • Intas Pharmaceuticals Limited
Drivers and Restrains

Male Infertility Treatment Market

The market is mainly driven by the steady increase in infertility rates globally. In addition, change in lifestyles and growing ageing population are also influencing the growth of the male infertility drugs market over the forecast period. Furthermore, recent advancements in infertility treatment and growing awareness related to the available treatment options and drugs are expected to bolster the market growth during the forecast period. However, unavailability of effective therapies or drugs for the treatment and social inhibitions are expected to hamper the male infertility drugs market during the forecast period. The market is driven by the steady growth rate in infertility, rising burden of conditions such as obesity and smoking around the world who are more susceptible to become infertile. Companies are focusing on the development of new treatment methods to cope with the increase in demand for the male infertility treatment.


North-America Got Significant Share

Male Infertility Treatment Market

Geographically, the market has been segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America market is expected to grow at significant rates owing to the factors such as well-established healthcare infrastructure, favourable government policies and growing awareness regarding the various treatment options available. Europe is expected to grow at significant rates owing to developed healthcare infrastructure, growing awareness. Asia Pacific and African region is expected to grow at faster rates owing to a high number of cases in the region and developing healthcare infrastructure and expansion of multinational companies into developing countries such as India and China.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In June 2017, Sal Nature LLC, new market player launched FertileHerb, the first such herbal supplement made in the United States

Key

Key Features of the Report

Male Infertility Treatment Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Executive Summary
  2. Global Male Infertility Treatment Market Introduction
    • Global Male Infertility Treatment Market – Taxonomy
    • Global Male Infertility Treatment Market –Definitions
      • Product Type
      • Distribution Channel
  1. Global Male Infertility Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Male Infertility Treatment Market Dynamic Factors – Impact Analysis
    • Global Male Infertility Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Male Infertility Treatment Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Male Infertility Treatment Market, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Drugs
      • Clomiphene
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Tamoxifen
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Hormones
        • Gonadotropin hormone
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Recombinant Follicle Stimulation Hormone
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Supplements
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
  1. Global Male Infertility Treatment Market Forecast, By Distribution Channel,2015 – 2019 and Forecast, 2020 – 2026
    • Hospital Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Male Infertility Treatment Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Male Infertility Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel and Region, 2020 – 2026
  2. North America Male Infertility Treatment MarketAnalysis,2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Drugs
        • Clomiphene
        • Tamoxifen
        • Others
      • Hormones
        • Gonadotropin hormone
        • Recombinant Follicle Stimulation Hormone
      • Supplements
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Male Infertility Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel and Country, 2020 – 2026
    • North America Male Infertility Treatment Market Dynamics – Trends
  3. Europe Male Infertility Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Drugs
        • Clomiphene
        • Tamoxifen
        • Others
      • Hormones
        • Gonadotropin hormone
        • Recombinant Follicle Stimulation Hormone
      • Supplements
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Male Infertility Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel and Country, 2020 – 2026
    • Europe Male Infertility Treatment Market Dynamics – Trends
  4. Asia-Pacific Male Infertility Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Drugs
        • Clomiphene
        • Tamoxifen
        • Others
      • Hormones
        • Gonadotropin hormone
        • Recombinant Follicle Stimulation Hormone
      • Supplements
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Country Analysis2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Male Infertility Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel and Country, 2020 – 2026
    • Asia-Pacific Male Infertility Treatment Market Dynamics – Trends
  5. Latin America Male Infertility Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Drugs
        • Clomiphene
        • Tamoxifen
        • Others
      • Hormones
        • Gonadotropin hormone
        • Recombinant Follicle Stimulation Hormone
      • Supplements
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Male Infertility Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel and Country, 2020 – 2026
    • Latin America Male Infertility Treatment Market Dynamics – Trends
  6. Middle East and Africa Male Infertility Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Drugs
        • Clomiphene
        • Tamoxifen
        • Others
      • Hormones
        • Gonadotropin hormone
        • Recombinant Follicle Stimulation Hormone
      • Supplements
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Male Infertility Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel and Country, 2020 – 2026
    • MEA Male Infertility Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • OncBioMune Pharmaceutical (U.S.)
      • The Merck Group (EMD Serono Inc.) (Germany)
      • Endo International plc (U.S.)
      • Sanofi (France)
      • SalNature, LLC (U.S.)
      • Active Bio Life Science GmbH (Germany)
      • Bayer AG (Germany)
      • Intas Pharmaceuticals Limited
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • OncBioMune Pharmaceutical (U.S.)
  • The Merck Group (EMD Serono Inc.) (Germany)
  • Endo International plc (U.S.)
  • Sanofi (France)
  • SalNature, LLC (U.S.)
  • Active Bio Life Science GmbH (Germany)
  • Bayer AG (Germany)
  • Intas Pharmaceuticals Limited

Description

Male Infertility Treatment Market is forecasted to value over USD 5.3 billion by 2027 end and register a CAGR of 4.8% from the forecast period 2021-2027. male infertility refers to the inability of male to cause pregnancy in a fertile woman. A variety of the problems ranging from hormonal disturbances to physical, psychological problems can cause male infertility. Hormonal problems include hyperprolactinemia, hypothyroidism, panhypopituitarism and others. Physical problems include varicocele, torsion, damaged sperm ducts and others. Furthermore, Erectile dysfunction, premature ejaculation and ejaculatory incompetence may lead to male infertility. Although many treatments are available for male infertility, in many cases treatment will not work. In many of the cases, male infertility is caused by testicular damage that leads to the inability of sperm production. In addition, low sperm production and poor sperm quality are also major causes of male infertility. Drugs, hormonal therapy, and assisted reproductive technology make up the global male infertility treatment market (ART). Clomiphene citrate and tamoxifen are two drugs used to treat male infertility. Human chorionic gonadotropin hormone (hCG) and recombinant follicle stimulating hormone (rFSH) are two types of hormone therapy (rFSH). Patients are given gonadotropin treatment to increase their testosterone levels. If these medicines do not work after 6 to 12 months of treatment, assisted reproductive technologies may be a possibility. In vitro fertilization-embryo transfer (IVF-ET), gamete intrafallopian transfer (GIFT), frozen embryo transfer (FET), and zygote intrafallopian transfer (ZIFT) are the several types of assisted reproductive technologies (ZIFT).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX